The only big mover was IKA:Ilika, which rose 13% on the back of a 14% rise last week wo earn Share of the Week again.This is now only 12% down.
Here's the ISA and share accounts snapshot
| Weekly Change | |||
| Cash | £11.99 | -£3.75 | |
| Portfolio cost | £57,768.95 | +£0 | |
| Portfolio sell value (bid price-commission) | £42,329.65 | (-27.5%) | -£452.46 |
| Potential profits | £0 | +£0 | |
| Yr 5 Dividends | £0.63 | +£0 | |
| Yr 5 Profit from sales | £-167.28 | +£0 | |
| Yr 5 Average monthly cash profit | -£34.93 | (-0.7%) | +£0.85 |
| Total Dividends | £1,342.93 | +£0 | |
| Total Profit from sales | £20,224.13 | +£0 | |
| Average monthly cash profit | £400.63 | (8.3%) | -£1.81 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Performance/Injection | 13.0% | +0% | |
| Compound performance | 57% | +0% |
The biggest drop was caused by a 1p fall in OPTI:Optibiotix.
Here's the SIPP after week 215
| Weekly Change | ||||
| Cash | £74.75 | -£16.22 | ||
| Portfolio cost | £46,995.31 | +£0 | ||
| Portfolio sell value (bid price - commission) |
£38,116.17 | (-18.9%) | -£498.64 | |
| Potential profits | £752.97 | +£60.00 | ||
| Yr 5 Dividends | £0 | +£0 | ||
| Yr 5 Interest | £0.02 | +£0.01 | ||
| Yr 5 Profit from sales | £0 | +£0 | ||
| Yr 5 Average monthly cash profit | -£17.69 | (-0.4%) | -£8.77 | |
| Total Dividends | £1,899.24 | +£0 | ||
| Total Interest | £0.18 | +£0.01 | ||
| Total Profit from sales | £12,549.10 | +£0 | ||
| Average monthly cash profit | £283.34 | (7.2%) | -£1.33 | |
| (Sold stocks profit + Dividends - Fees / Months) | ||||
| Performance/Injection | 11.3% | -0.1% | ||
| Compound performance | 47% | +0% |
Similar story to above, but an extra £60 on CAML:Central Asia Metals potential profits and cash and year 5 monthly average profits down due to monthly charges.
Here's the trading portfolio after Week 181
| Weekly Change | |||
| Cash | £48.24 | +£0 | |
| Portfolio cost | £2,321.29 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,281.23 | (-44.8%) | -£1.57 |
| Potential profits | £0 | +£0 | |
| Year 4 Dividends | £13.20 | +£0 | |
| Year 4 Profit | £0 | +£0 | |
| Yr 4 Average monthly cash profit | £2.29 | (1.2%) | -£0.09 |
| Dividends | £47.92 | +£0 | |
| Profit from sales | -£64.29 | +£0 | |
| Average monthly cash profit | -£0.39 | (-0.2%) | +£0 |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Performance/Injection | -0.2% | +0% | |
| Compound performance | -1% | +0% |
Hardly any change here
No comments:
Post a Comment